Dessie ZG,Zewotir T .2021 .Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis, 21(1) : 855.
.2023 .. Weekly epidemiological update on COVID-19 - 1 September, : .
. .. epidemiological-update-on-covid-19---1-september-2023, : .
.2015 .. , 33 : 823-874.
Zanza C,Romenskaya T,Manetti AC,Franceschi F,La Russa R,Bertozzi G . .. Medicina (Kaunas)., : .
.2022 .. PMID: 35208467 DOI: 10.3390/medicina58020144, 58(2) : .
.2020 .. , 383(23) : 2255-2273.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. , 6736(20) : 30183-5.
Zhu Z,Cai T,Fan L,Lou K,Hua X,Huang Z .2020 .Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis, 95 : 332-339.
.2020 .. PMID: 32334118 DOI: 10, 04 : .
Ruan Q,Yang K,Wang W,Jiang L,Song J. . .Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med., : .
.2020 .. , 46(5) : 846-848.
Ronco C,Bellomo R. Hemoperfusion C .2022 .: technical aspects and state of the art. Crit Care, 26(1) : 135.
Ankawi G,Fan W,Pomarè Montin D,Lorenzin A,Neri M,Caprara C .2019 .A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions. Blood Purif, 47(1-3) : 94-100.
Clark EG,Hiremath S,McIntyre L,Wald R,Hundemer GL,Joannidis M. .2020 .Haemoperfusion should only be used for COVID19 in the context of randomized trials. Nat Rev Nephrol, 16(12) : 697-699.
Mo P,Xing Y,Xiao Y,Deng L,Zhao Q,Wang H .2019 .. Clinical Characteristics of Refractory Coronavirus Disease, : .
Xie J,Covassin N,Fan Z,Singh P,Gao W,Li G .2020 .. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc, 04(6) : 1138-1147.
Zhou F,Yu T,Du R,Fan G,Liu Y,Liu Z .2020 .Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 6736(20) : 30566-3.
Soleimani A,Taba SMM,Hasibi Taheri S,Loghman AH,Shayestehpour M. . .The effect of hemoperfusion on the outcome, clinical and laboratory findings of patients with severe COVID19: a retrospective study. New Microbes New Infect., : .
Peng JY,Li L,Zhao X,Ding F,Hou X .2022 .Hemoperfusion with CytoSorb® in Critically Ill COVID-. Patients. Blood Purif, 51(5) : 410-416.
Surasit K,Srisawat N. .2022 .The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study. Blood Purif, 51(11) : 879-888.
Pomarè Montin D,Ankawi G,Lorenzin A,Neri M,Caprara C .2018 .Biocompatibility and Cytotoxic Evaluation of New Sorbent Cartridges for Blood Hemoperfusion. Blood Purif, 46(3) : 187-195.